American Society of Hematology

The Hematologist: ASH News and Reports, the Society's member newsletter, is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

banner image

Podcast: The Unfiltered Truth

Drs. Garcia and Gotlib carry out a discussion about the benefits of well managed anticoagulation in patients with high risk pulmonary embolism.

Read more
banner image

Do We Need Another HDAC Inhibitor in Multiple Myeloma? 

Drs. Raje and Yee discuss the need for new agents in the treatment of patients with MM, taking into account FDA approval of penobinostat.

Read more
banner image

Program Genealogies: Myeloma at Mayo

Dr. Rajkumar discusses how Dr. Robert Kyle started and developed the Multiple Myeloma Program at the Mayo Clinic. Dr. Kyle reflects on the success of the program for over 50 years.

Read more
View All

Presidents Column

Dr_ David A_ Williams - Presidents Column

David A. Williams, MD

Chief of Hematology/Oncology; Director of Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts
ASH as a Global Organization
June 11, 2015

Dr. Williams discusses ASH's international presence through various programs and initiatives; he highlights the need for support for several changes in governance and membership structure to help ASH advance as a global organization.

View All

Clinical Trials Corner

Do We Need Another HDAC Inhibitor in Multiple Myeloma?
June 8, 2015

Dr. Raje and Dr. Yee discuss the need for new agents in the therapy or treatment of patients with multiple myeloma, taking into account the FDA approval of penobinostat, and a study that looks at HDAC inhibition.

View All

Ask The Hematologist

Ask the Hematologist: Treating Patients with Relapsed/Refractory Hairy Cell Leukemia
June 18, 2015

Dr. Kreitman talks about his management approaches to treating patients with relapsed or refractory hairy cell leukemia.

View All

Mini Review

Desialylated Platelets: A Missing Link in Hepatic Thrombopoietin Regulation
April 14, 2015

Drs. Falet, Grozovsky, and Hoffmeister look at desialylated platelets to understand the steady state of hepatic TPO regulation and the mechanisms of thrombocytopenia observed in patients with MPNs treated with JAK1/2 inhibitors.

View All

Op Ed

Is the NIH Expert Report on Sickle Cell Disease a “Clinical Practice Guideline We Can Trust?”
November 19, 2014

Dr. Alexis Thompson makes a thorough assessment of the latest clinical practice guidelines for sickle cell disease.

View All
  • Medicare Releases Proposed Payment Rates and Associated Policies for Physicians in 2016

    On July 8, 2015, the Centers for Medicare and Medicaid Services (CMS) released its proposed rule  governing payments for physician services and other associated policies covering the calendar year of 2016.  This is the first physician fee schedule proposed rule following the passage of the Medicare Access and CHIP Reauthorization Act (MACRA), which eliminated the sustainable growth rate formula that had long mandated cuts each year.  Please follow the link above to learn more.

  • Let ASH Know About Difficulties in Obtaining Guaranteed Coverage for Clinical Trials

    Guaranteeing access to clinical trials for cancer patients has long been a priority for ASH.  Recently, the Departments of Health and Human Services and Labor (which are both responsible for implementing the various provisions of the health reform law) announced there would not be federal regulations to implement the clinical trials coverage provision of the health reform law.  The agencies determined the statutory language was self-implementing, and indicated that the Departments do not expect to issue regulations in the near future.  Please follow the link above to learn more about this issue.

  • How the CMS Plans for ICD-10 Implementation Will Affect Hematologists

    The Centers for Medicare and Medicaid Services (CMS) has announced a new plan that will introduce some leniency in the introduction of the new ICD-10 diagnosis coding system.  Most notably, claims will not be rejected if the diagnosis coding is not to the correct level of specificity.  To see an example from the field of hematology, please follow the link.  ASH staff has prepared a full article giving an example of the diagnosis coding for lymphoid leukemia.

  • A Report from the AMA House of Delegates

    In the first weekend of June in Chicago, representatives from medical specialty societies and state medical societies convened a meeting of the semi-annual American Medical Association (AMA) House of Delegates.  The House of Delegates is composed of more than 500 physician representatives, and they consider resolutions covering a wide gamut of issues, such as health information technology, maintenance of certification, and menu labeling for food allergies.  ASH was represented at the meeting this year.  Follow the link to read more.

View all policy news
back to top